NICE offers advice on gastro-oesophageal reflux in childrenThe National Institute for Health and Care Excellence has published its first clinical guideline on the management of gastro-oesophageal reflux disease in infants and children.…
Developing studies to test drug safety as a research fellow In her role as principal research fellow at the Drug Safety Research Unit, Deborah Layton uses principles of pharmacoepidemiology to develop studies to help assess the safety of drugs.…
The public trusts pharmacists but not to the same degree as other health professionals, survey shows The public trusts the advice given by a community pharmacist but the degree of trust is lower than that afforded to other health professionals, according to an IPSOS/Mori poll.…
Risk of heart problems prompts removal of OTC diclofenac from UK pharmacy shelves Oral diclofenac tablets, used for short-term pain relief, will no longer be available as an over-the-counter pharmacy medicine in the UK.…
Osteoporosis: a disease of the modern world?A lack of vigorous exercise has caused human bones to become weaker over thousands of years.…
Dulaglutide launched in the UK as once-weekly diabetes treatmentThe second once-weekly non-insulin injection for patients with type 2 diabetes became available in the UK from 13 January 2015.…
Increased risk of severe skin reactions with expectorants containing ambroxol or bromhexinePatients taking expectorants containing ambroxol or bromhexine have a small increased risk of severe skin reactions such as Stevens-Johnson syndrome.…
Pharmacy urged to push for role in new models of care RPS calls for local leaders to ensure pharmacy is included in pilots of new models of care.…
NHS England drops therapies from cancer drugs fund to save £80m A total of 25 clinical indications will be removed from the government’s cancer drugs fund list, NHS England has announced.…
Alternative to standard artemisinin combination therapy identified for children with uncomplicated malaria Artemisinin-naphthoquine given as three daily doses offers an alternative to artemether-lumefantrine, which is given as six doses over three days.…